Walgreens Boots Alliance Inc (WBA), a leading healthcare, pharmacy, and retail company, is set to release its Q1 earnings report before the market opens on Thursday, January 9, 2025. The company operates through its U.S. Retail Pharmacy, International, and U.S. Healthcare segments, boasting a market capitalization of $8.3 billion.
Is now the time to buy WBA:NSD? Access our full analysis report here, it’s free.
Expected Q1 Earnings Report of Walgreens Boots Alliance Inc:
Analysts project that Walgreens will report a profit of $0.37 per share for Q1 2025, a significant 43.9% decline from the $0.66 per share reported in the same quarter last year. Despite this, Walgreens has a strong track record, having surpassed Wall Street’s earnings per share (EPS) estimates in three of the past four quarters. In its last reported quarter, the company’s adjusted EPS outperformed consensus estimates by 8.3%.
Looking ahead to fiscal 2025, analysts anticipate an adjusted EPS of $1.52, a 47.2% drop compared to $2.88 in fiscal 2023.
Stock Target Advisor’s Analysis on Walgreens Boots Alliance Inc:
According to Stock Target Advisor, Walgreens Boots Alliance Inc holds a “Bullish” rating. This assessment is supported by eight positive signals, including high market capitalization, low volatility, superior total returns, and being undervalued compared to its peers on price-to-book and price-to-cash flow metrics. The stock has also demonstrated strong dividend growth over the past five years.
However, the analysis also highlights three negative signals: high leverage, negative free cash flow, and below-average revenue growth over the past five years.
Explore the ETFs linked to Walgreens Boots Alliance for insights into its market positioning and performance!
Conclusion:
As Walgreens Boots Alliance prepares to report its Q1 earnings, the market will closely scrutinize its performance and strategic initiatives to address financial pressures. While the company’s financial results have faced headwinds, its long-term growth prospects and cost-cutting measures may provide a pathway to recovery.
Discover more about the best-performing companies and explore Walgreens Boots Alliance’s position among the Top Stocks!
With mixed ratings from analysts and cautious optimism from Stock Target Advisor, investors will await Thursday’s announcement for further clarity on WBA’s trajectory.
Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product/services forecast as indicated by major brokers covering the stock.
